
Just Started Mounjaro What Indian Patients Should Expect in the First 4 Weeks
Starting a new medication like Mounjaro (tirzepatide) for type 2 diabetes can bring hope, questions, and a few unexpected turns. For Indian patients newly diagnosed with diabetes and who have just been prescribed Mounjaro, this article will help understand what lies ahead over the next four weeks, both the positive progress and the typical hurdles.
This human-centred guide gives a week-by-week breakdown of what you might feel physically and emotionally. We also address Mounjaro start effects, common Mounjaro side effects, and when to seek help from your doctor.
Week 1: Getting Used to the Injection The first week with Mounjaro is largely about adjustment. For many patients, especially those who've never taken injectable medications before, the thought of using a needle can be daunting. But rest assured, Mounjaro is a once-weekly injection with an ultra-fine, pre-filled pen designed for ease.
1. What to Expect? • Minimal pain: Most patients report a slight pinch or no pain at all.
• Injection sites: Common areas include the stomach (abdomen), upper thigh, or the back of the arm. Rotate the site weekly to avoid skin irritation.
• First-day symptoms: Some patients report feeling unusually tired, a bit light-headed, or mildly nauseated within a few hours of their first dose. This is your body adjusting to how the medicine slows down digestion and begins regulating blood sugar.
2. Emotional Adjustment • There may be emotional anxiety about taking a long-term injection therapy. But many Indian patients find reassurance in the structure it provides. One injection a week means fewer daily reminders of the illness.
• You might also feel hopeful, especially if your doctor shared promising data on Mounjaro's dual benefits for sugar control and weight loss.
Tip: Track how you feel in a diary or on your phone. It can help during your follow-up visits.
Week 2: Sugar Changes By the second week, Mounjaro start effects begin to kick in noticeably. The medication mimics two key hormones, GLP-1 and GIP, which work together to help your body release insulin when needed, lower the amount of sugar released by the liver, and slow gastric emptying. This leads to more stable blood sugar levels.
1. What to Expect? • Reduced post-meal spikes: You may notice that your blood sugar levels don't shoot up as dramatically after meals. This is especially noticeable after high-carb Indian foods like rice, parathas, or sweets.
• Mild hypoglycaemia (low blood sugar): Though rare in the first few weeks, if you're on other diabetic medications like insulin or sulfonylureas, you could feel symptoms like shakiness, sweating, or confusion. Always carry a quick sugar source, like glucose tablets or a small banana.
2. Emotional Response • Many patients feel encouraged seeing better sugar readings, sometimes for the first time since their diagnosis.
• However, some might feel frustrated if they haven't seen drastic changes yet. This is completely normal. Mounjaro works gradually and sustainably.
Tip: Make sure you're checking your blood sugar at the times recommended by your doctor. Sharing this data helps guide future dose decisions.
Week 3: Noticing Weight Shifts One of the most talked-about Mounjaro start effects is its role in supporting weight loss. By Week 3, subtle changes in weight may begin to emerge.
1. What to Expect? • Decreased appetite: You may feel full with smaller meals. Mounjaro slows down how quickly food moves through your stomach, which can keep hunger at bay longer.
• Food aversions: Some patients begin to find oily or fried foods less appealing. This is common and often considered a benefit.
• Initial weight loss: Many Indian patients notice a 1–3 kg drop in the first three weeks, especially if they've made dietary changes alongside the medication.
2. Emotional Impact • Feeling lighter, physically and emotionally, can boost self-esteem.
• But be wary of pushing your body too hard. Some individuals may try to over-exercise or under-eat to speed up results. Always focus on sustainable lifestyle changes, not extreme shifts.
Tip: Add a simple 20-minute walk post-dinner. It enhances Mounjaro's glucose-lowering and weight-loss effects.
Common Side Effects Timeline Understanding Mounjaro side effects can help you prepare, manage, and stay on course with your treatment plan. While not everyone experiences side effects, here's a timeline based on typical patient experiences in India.
1. Week 1 to 2: Digestive Discomfort • Nausea: The most common early side effect. Eating smaller meals, avoiding spicy or fried foods, and staying hydrated can help.
• Constipation: Due to slower digestion. Add fibre-rich Indian foods like sabudana, fruits, or soaked raisins.
• Bloating or gas: Especially after eating starchy or fried items.
2. Week 2 to 3: Appetite & Taste Changes • Some patients find themselves repelled by previously enjoyed foods. This is temporary and part of the body adjusting to new hunger signals.
• A metallic taste in the mouth or altered sense of flavour can occur but usually resolves within a month.
3. Week 3 to 4: Mood and Energy • As sugar levels stabilise, many people feel more energised.
• But some might feel fatigued due to lower calorie intake. Ensure balanced nutrition, even with reduced appetite.
4. Rare but Serious Side Effects (at any point) • Severe stomach pain, especially if persistent or accompanied by vomiting, may signal pancreatitis.
• Allergic reaction: Swelling, rash, or breathing difficulty needs urgent medical attention.
Note: Consult your doctor immediately if side effects persist or become severe. Mounjaro is available in 2 sizes: Mounjaro 2.5 mg and Mounjaro 5 mg. Please check with your doctor for your needs.
When to Contact Your Doctor? Starting Mounjaro is a commitment, not just to a medication, but to ongoing care. Here's when you should absolutely reach out to your doctor: 1. Persistent Side Effects If nausea, vomiting, or diarrhoea lasts more than 3 days or severely affects your food intake, speak with your doctor. They may adjust your dose or suggest dietary tweaks.
2. Unexplained Hypoglycaemia Even if you're not on insulin, notify your doctor if your sugar readings consistently fall below 70 mg/dL, or if you feel faint, dizzy, or confused.
3. Injection Site Reactions A little redness or mild swelling is normal. But if the area becomes very painful, warm, or starts to ooze, seek advice.
4. Emotional Changes Diabetes medications can indirectly affect your mood and energy. If you're feeling unusually low, anxious, or overwhelmed, talk to your healthcare provider. Mental wellness is just as important.
5. Missed Doses If you miss a dose and it's within 4 days of the scheduled time, take it as soon as possible. If more than 4 days have passed, skip it and continue with the next scheduled dose. But inform your doctor for further guidance, especially in the early weeks.
top videos
View all
Conclusion: Embracing the First Month with Realistic Expectations Mounjaro isn't a magic cure; it's a powerful tool. Indian patients starting this journey should remember that the first few weeks are about listening to their body. Improvements in blood sugar and weight loss will come, but everyone's pace is different. Emotional fluctuations are just as common as physical ones, and both deserve attention. In a healthcare landscape where type 2 diabetes is increasingly common, medications like Mounjaro offer much-needed hope, especially when introduced early. If you approach the first four weeks with patience, awareness, and the right support system, you're setting yourself up for long-term success, not just in managing diabetes but in improving overall health. Always partner with your doctor for dose adjustments, side effect management, and lifestyle tips. And remember: you're not alone in this. Millions of patients across India are walking the same path, with the same questions, hopes, and courage.
(Disclaimer: The above press release comes to you under an arrangement with NRDPL and PTI takes no editorial responsibility for the same.). PTI PWR PWR
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments
First Published:
July 22, 2025, 17:45 IST
News agency-feeds Just Started Mounjaro What Indian Patients Should Expect in the First 4 Weeks
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fashion Value Chain
22 minutes ago
- Fashion Value Chain
Xavier University School of Medicine, Aruba and KLE University Launch International Medical Program for Indian Students Aspiring to Practice in the US and Canada
With a growing number of Indian students aspiring to pursue medical education and careers in the United States, Canada, and beyond, Xavier University School of Medicine, Aruba (XUSOM), in collaboration with KLE University, India, has launched a unique international medical pathway to support this ambition. This innovative program allows students to begin their medical journey in India at KLE University's Belgaum campus, continue with their preclinical sciences education at XUSOM, and then complete clinical rotations at Xavier's affiliated and accredited teaching hospitals across the United States. Students will spend the first year completing pre-health coursework at KLE's campus in Belgaum, India. They will then advance to Xavier's state-of-the-art campus in Aruba for basic science training before transitioning to hands-on clinical experiences in the United States. By starting their studies at KLE and transitioning smoothly to Xavier University in Aruba, students benefit from a unique and accessible pathway to a global medical career. Designed specifically for high school graduates and aspiring doctors aiming to practice in North America, this program offers a seamless, structured path to meet the rigorous standards required for medical licensure in the US and Canada. 'This association presents a clear and compelling opportunity for students in India who dream of becoming doctors in North America,' said Mamta Purbey, Director of Admissions & Marketingat XUSOM. 'We take pride in offering Indian students not only a robust academic curriculum but also personalized guidance and support throughout their medical education journey. Our dedicated team ensures students navigate each stage smoothly – from admission through clinical rotations – equipping them to successfully achieve their goal of practicing medicine in the US, and Canada.' 'This collaboration brings together a globally aligned medical curriculum taught by experienced and highly qualified faculty, ensuring students gain the knowledge, skills, and international exposure needed to excel in today's competitive medical field,' said Dr. Arun Kumar Dubey, Chief Academic Officerof XUSOM. 'Our mission is to eliminate uncertainty for aspiring medical professionals by offering a clear, structured, and academically rigorous pathway – from India to Aruba to the United States – ultimately preparing them to succeed in medical practice across North America.' 'This partnership marks a significant step toward removing barriers and providing clear guidance for Indian students determined to pursue a medical career abroad.' 'This partnership with KLE University represents a shared commitment to creating accessible, world-class medical education pathways for talented students in India,' said Ravi Bhooplapur, President of XUSOM. 'By combining KLE's strong foundation in pre-health sciences with Xavier's globally recognized medical curriculum and clinical training opportunities in the United States, we are empowering the next generation of doctors to achieve their dream of practicing medicine in North America.' For more details on Xavier University School of Medicine visitXUSOM Website.


Hindustan Times
22 minutes ago
- Hindustan Times
Indian diplomat visits Syria for meetings with regime led by al-Sharaa
New Delhi: India has made a formal outreach to Syria's provisional government led by former Hay'at Tahrir al-Sham (HTS) leader Ahmed al-Sharaa, with a middle-ranking diplomat visiting Damascus for meetings with Syrian ministers. Syria's interim President Ahmed al-Sharaa. (REUTERS) This was the first official visit to Damascus from the Indian side since al-Sharaa, whose group was once affiliated to al-Qaeda, assumed power after ousting the regime of Bashar al-Assad following a lightning offensive last December. There was no official word from the Indian side on the visit by Suresh Kumar, director of the West Asia and North Africa (WANA) division of the external affairs ministry. Kumar's meetings with Syria's foreign and education ministers in Damascus on Monday were reported by State-run SANA news agency. 'A beginning had to be made and India had to register its presence. You have to open the door at some point,' a person familiar with the matter said on condition of anonymity. Syria's foreign minister Asaad Al-Shaibani and the Indian delegation led by Kumar discussed 'issues of mutual concern and ways of enhancing relations between the two countries in the interests of both peoples', SANA reported. The meeting between Kumar and Syrian health minister Musab Al-Ali focused on enhancing health cooperation, particularly in the fields of pharmaceutical industries and medical training, according to another report by SANA. The two sides also discussed a mechanism for implementing a scholarship for Syrian students, and allocating a specialised engineering cooperation programme for government employees. Al-Ali stressed Syria's aspiration to establish a strong partnership with India in pharmaceutical industries and health technologies in order to support the national health sector and provide medicines. Kumar said India will continue funding specialised training courses for Syrian personnel, coordinate the training of Syrian doctors in Indian centres, and enhance cooperation in nursing, pharmaceutical industries and pharmaceutical exports, the report said. India has had strong political ties with Syria and both countries were key members of the Non-Aligned Movement. India's traditional support for Arab causes such as the issue of Palestine was appreciated by Syria. India also backed Syria's right to the Golan Heights, currently occupied by Israel, and its full return to the country. Under the Assad family, the Syrian government usually backed India at multilateral forums, including on the issue of Kashmir. In response to a request from Damascus for emergency humanitarian aid in 2021, the Indian government gifted 2,000 tonnes of rice to Syria. During the Covid-19 pandemic, India sent 10 tonnes of medicines to Syria. This was the largest medical assistance from any country to Syria during the pandemic. India has been monitoring the situation in Syria since the fall of the Assad regime in December 2024. At the time, India evacuated 77 Indian nationals from Syria. 'We hope that the new constitution, due to be drafted, takes into account the interests of all the sections of the Syrian society,' the external affairs ministry said in a statement around the time of the change of government. In January, al-Sharaa, a former al-Qaeda commander who went by the name Abu Mohammad al-Jolani, became president of the provisional government. People familiar with the matter said the outreach to Damascus was influenced by Syria's strategic location in West Asia – the country shares borders with five key regional actors, Turkey, Iraq, Jordan, Israel and Lebanon – and the long-standing ties between the two sides. The outreach also follows the US decision to end sanctions on Syria after a meeting between al-Sharaa and President Donald Trump in May.


India Today
an hour ago
- India Today
PETA India calls out Oreo maker for 'senseless' animal testing. Key details
People for the Ethical Treatment of Animals (PETA) India has sent a letter to Mondelz, the manufacturer of the popular cookie variety 'Oreo', urging the management to permanently stop animal testing that is not expressly required by law, such as one experiment that had involved force-feeding human feces to Mondelz adopted a limited global ban on animal testing in 2018 after consulting with PETA US, a loophole continues to allow animal testing under the guise of promoting basic 'nutritional science'.advertisementMondelz claims not to test products on animals unless required by law, but the company has funded numerous 'nutritional science' experiments such as force-feeding mice with human faecal bacteria, which have been shown to produce no health-relevant results for humans.'Force-feeding mice with harmful faecal bacteria, chemicals and glass beads is completely unacceptable and should have been banned long ago - especially when these experiments have no scientific or legal basis,' said Dr Anjana Aggarwal, PETA India's Scientist and Research Policy Advisor.'We call on Mondelz to finally turn its back on animal testing and join the many companies that have joined PETA's 'Eat without Experiments' program. The damage to brand reputation from continuing to conduct or fund these tests is growing by the day, and consumers worldwide no longer want to support it.' she added. PETA India calls out Oreo maker for 'senseless' animal testing. Key details PETA India and food manufacturers around the world take action against senseless testingCommon food ingredients, for which there are no toxicity concerns, should not be tested on animals. Studies such as these could be carried out safely with consenting human volunteers, which, unlike animal testing, would allow clinically relevant results to be obtained. A large number of modern in vitro and computer models can also be used to research the effects of food on human than 128,000 consumers have contacted Mondelz through online action alerts via PETA India, PETA Germany, PETA US, PETA UK, PETA France, PETA Netherlands, PETA Australia, PETA Latino, and PETA2, to call for a ban on animal than 400 food and beverage companies - including Ferrero and Unilever - have already signed up to PETA's Eat Without Experiments program, pledging to refrain from non-legally required animal authorities worldwide: no acceptance of animal testingPETA US has already sent Mondelz a scientific critique highlighting the weaknesses of these animal New Drugs and Clinical Trials (Amendment) Rules 2023, passed by the Indian government, allows for the use of non-animal methods for assessing drug safety and efficacy, replacing traditional animal US National Institutes of Health (NIH) also recently announced its intention to launch 'a new initiative to expand innovative, human-based science while reducing animal use in research'. The European Food Safety Authority (EFSA), the US Food and Drug Administration (FDA), the Food Directorate of Canada Health and other institutions do not accept animal testing as the sole evidence for health claims for foods.- EndsTrending Reel